GSK180

GSK180
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay19217-1 1 mg - -

5 - 10 business days*

55.00€
Cay19217-5 5 mg - -

5 - 10 business days*

229.00€
Cay19217-10 10 mg - -

5 - 10 business days*

376.00€
Cay19217-25 25 mg - -

5 - 10 business days*

670.00€
 
An inhibitor of kynurenine 3-monooxygenase (IC50 = 6.3 nM), selective for human over P.... more
Product information "GSK180"
An inhibitor of kynurenine 3-monooxygenase (IC50 = 6.3 nM), selective for human over P. fluorescens kynurenine 3-monooxygenase (IC50 = 500 nM), increases circulating levels of kynurenine and kynurenic acid in mice at 27 mg/kg, protects against secondary acute lung injury and renal injury in a rat model of experimentally induced AP-MODS. Formulation: A solid. InChI: InChI=1S/C10H7Cl2NO4/c11-5-3-7-8(4-6(5)12)17-10(16)13(7)2-1-9(14)15/h3-4H,1-2H2,(H,14,15). InChIKey: MIGAKMWKMLYGJX-UHFFFAOYSA-N. SMILES: O=C1N(CCC(O)=O)C2=CC(Cl)=C(Cl)C=C2O1
Keywords: 5,6-dichloro-2-oxo-3(2H)-benzoxazolepropanoic acid
Supplier: Cayman Chemical
Supplier-Nr: 19217

Properties

Application: Kynurenine 3-monooxygenase inhibitor
MW: 276.1 D
Formula: C10H7Cl2NO4
Purity: >95%
Format: Solid

Database Information

CAS : 1799725-26-0| Matching products
KEGG ID : K00486 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GSK180"
Write a review
or to review a product.
Viewed